Optimmune Eye Ointment

SCHERING Optimmune Eye Ointment -  3.5gm
SKU : 6107_-RX
Price: $34.95
Veterinarian Prescription (Rx) Required
Free Shipping on orders over $75
Low Price Match Guarantee
3.5gm Ointment
RX required for this item.
Click here for our full Prescription Policy and Form

Ophthalmic ointment with .2% Cyclosporine, USP. For use in dogs only.

Features and Benefits
  • The only FDA-approved veterinary cyclosporine ophthalmic product.

  • Achieves therapeutic effect while avoiding systems toxicity.

  • Sterile, preservative-free formulation reduces the chance of secondary infection and chemical irritation.

  • Shelf life up to 24 months with no refrigeration.

DESCRIPTION:
Each gram of OPTIMMUNE Ophthalmic Ointment contains 2 mg of cyclosporine, USP; petrolatum, USP; corn oil, NF; and Amerchol® CAB base. Cyclosporine (cyclosporin A), the active ingredient of OPTIMMUNE Ophthalmic Ointment, is a cyclic undecapeptide metabolite of the fungus Tolypocladium inflatum gams.

DOSAGE AND ADMINISTRATION:

  • Remove debris with suitable nonirritating solutions. Apply a 1/4 inch strip of ointment to the affected eye(s) every 12 hours. The ointment may be placed directly on the cornea or into the conjunctival sac.
  • It is recommended that dogs exhibiting chronic recurring conjunctivitis be tested for adequate tear production to determine if they are suffering from early stages of chronic KCS.
  • For best results in treating KCS, cyclosporine ophthalmic ointment should be administered early in the course of the disease before irreversible damage to the lacrimal tissue, or dense corneal scarring or pigmentation occurs.
  • Dogs afflicted with KCS or CSK will most likely require lifelong consistent therapy (see EFFICACY section). For CSK, because environmental factors such as ultraviolet (UV) radiation are implicated in the pathogenesis, clinical signs may subside in the winter months when light intensity is reduced or if the dog is moved to a lower altitude, or indoors, and thus exposed to less UV radiation.1
  • In cases refractory to cyclosporine, the diagnosis should be re-evaluated and a different course of therapy considered. Periodic reassessment of the need for OPTIMMUNE Ophthalmic Ointment therapy is recommended.

Customer Reviews
(4.33)
# of Ratings: 3
RX required for this item.
Click here for our full Prescription Policy and Form

Ophthalmic ointment with .2% Cyclosporine, USP. For use in dogs only.

Features and Benefits
  • The only FDA-approved veterinary cyclosporine ophthalmic product.

  • Achieves therapeutic effect while avoiding systems toxicity.

  • Sterile, preservative-free formulation reduces the chance of secondary infection and chemical irritation.

  • Shelf life up to 24 months with no refrigeration.

DESCRIPTION:
Each gram of OPTIMMUNE Ophthalmic Ointment contains 2 mg of cyclosporine, USP; petrolatum, USP; corn oil, NF; and Amerchol® CAB base. Cyclosporine (cyclosporin A), the active ingredient of OPTIMMUNE Ophthalmic Ointment, is a cyclic undecapeptide metabolite of the fungus Tolypocladium inflatum gams.

DOSAGE AND ADMINISTRATION:

  • Remove debris with suitable nonirritating solutions. Apply a 1/4 inch strip of ointment to the affected eye(s) every 12 hours. The ointment may be placed directly on the cornea or into the conjunctival sac.
  • It is recommended that dogs exhibiting chronic recurring conjunctivitis be tested for adequate tear production to determine if they are suffering from early stages of chronic KCS.
  • For best results in treating KCS, cyclosporine ophthalmic ointment should be administered early in the course of the disease before irreversible damage to the lacrimal tissue, or dense corneal scarring or pigmentation occurs.
  • Dogs afflicted with KCS or CSK will most likely require lifelong consistent therapy (see EFFICACY section). For CSK, because environmental factors such as ultraviolet (UV) radiation are implicated in the pathogenesis, clinical signs may subside in the winter months when light intensity is reduced or if the dog is moved to a lower altitude, or indoors, and thus exposed to less UV radiation.1
  • In cases refractory to cyclosporine, the diagnosis should be re-evaluated and a different course of therapy considered. Periodic reassessment of the need for OPTIMMUNE Ophthalmic Ointment therapy is recommended.

Loading...